Cargando…
Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs—Influence of Smoking Behavior and Inflammation on Pharmacokinetics
Both inflammation and smoking can influence a drug’s pharmacokinetic properties, i.e., its liberation, absorption, distribution, metabolism, and elimination. Depending on, e.g., pharmacogenetics, these changes may alter treatment response or cause serious adverse drug reactions and are thus of clini...
Autores principales: | Moschny, Nicole, Hefner, Gudrun, Grohmann, Renate, Eckermann, Gabriel, Maier, Hannah B, Seifert, Johanna, Heck, Johannes, Francis, Flverly, Bleich, Stefan, Toto, Sermin, Meissner, Catharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230242/ https://www.ncbi.nlm.nih.gov/pubmed/34071813 http://dx.doi.org/10.3390/ph14060514 |
Ejemplares similares
-
COVID-19-Impfung unter Psychopharmakotherapie
por: Seifert, Johanna, et al.
Publicado: (2021) -
Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016
por: Glocker, Catherine, et al.
Publicado: (2023) -
Psychotropic drug-induced hyponatremia: results from a drug surveillance program–an update
por: Seifert, Johanna, et al.
Publicado: (2021) -
Psychopharmakotherapie in Zeiten der COVID-19-Pandemie
por: Seifert, J., et al.
Publicado: (2020) -
Galactorrhea during antipsychotic treatment: results from AMSP, a drug surveillance program, between 1993 and 2015
por: Glocker, C., et al.
Publicado: (2021)